Genetic deletion of HDAC4 in skeletal muscles caused earlier onset of ALS in a mouse model, suggesting a potential risk in use of HDACi for treatment of ALS (Pigna et al., 2019). The gene discussed is HDAC4; the disease is amyotrophic lateral sclerosis.